Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Undervalued stocks
Yield stocks
Growth stocks
Trend-Following Stocks
ESG stocks
Quality stocks
Investment Themes
Biotechnology
The Golden Age of Video Games
In Vino Veritas
Smart City
Sin stocks
Financial Data
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Smart City
In Vino Veritas
Water
Ageing Population
US Basketball
Financial Data
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Adamis Pharmaceuticals Corporation
News
Summary
ADMP
US00547W2089
ADAMIS PHARMACEUTICALS CORPORATION
(ADMP)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-08-08 pm EDT
0.3749
USD
+0.24%
07:31a
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update
AQ
08/01
ADAMIS PHARMACEUTICALS
: Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19 - Form 8-K
PU
08/01
ADAMIS PHARMACEUTICALS CORP
: Other Events (form 8-K)
AQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about ADAMIS PHARMACEUTICALS CORPORATION
07:31a
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call ..
AQ
08/01
ADAMIS PHARMACEUTICALS
: Provides Update on Clinical Study Assessing Tempol for the Treatm..
PU
08/01
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
08/01
Adamis Pharmaceuticals Corporation - Leading Independent Proxy Advisory Firm ISS Recomm..
AQ
07/29
THE DEADLINE FOR STOCKHOLDERS TO VOT
: 59 p.m. PT on August 11, 2022 - Form 8-K
PU
07/29
Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals' Stockhol..
AQ
07/29
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
07/29
Adamis Pharmaceuticals Corporation Provides Update on Clinical Study Assessing Tempol f..
CI
07/21
Adamis Pharmaceuticals Issues Letter to Stockholders
AQ
07/05
Adamis Pharmaceuticals Corporation announced that it has received $0.3 million in fundi..
CI
06/01
Adamis Pharmaceuticals Receives Data Safety Monitoring Board's Recommendation to Contin..
MT
06/01
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
06/01
Adamis Pharmaceuticals Corporation Provides Update on Clinical Study Assessing Tempol f..
CI
05/26
Adamis Appoints Vickie Reed to Board of Directors
AQ
05/26
Adamis Pharmaceuticals Corporation Appoints Vickie Reed to Board of Directors
CI
More most relevant news
All news about ADAMIS PHARMACEUTICALS CORPORATION
07:31a
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call ..
AQ
08/01
ADAMIS PHARMACEUTICALS
: Provides Update on Clinical Study Assessing Tempol for the Treatm..
PU
08/01
ADAMIS PHARMACEUTICALS CORP
: Other Events (form 8-K)
AQ
08/01
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
08/01
Adamis Pharmaceuticals Corporation - Leading Independent Proxy Advisory Firm ISS Recomm..
AQ
07/29
THE DEADLINE FOR STOCKHOLDERS TO VOT
: 59 p.m. PT on August 11, 2022 - Form 8-K
PU
07/29
ADAMIS PHARMACEUTICALS CORP
: Other Events (form 8-K)
AQ
07/29
Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals' Stockhol..
AQ
07/29
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
07/29
Adamis Pharmaceuticals Corporation Provides Update on Clinical Study Assessing Tempol f..
CI
More news
News in other languages on ADAMIS PHARMACEUTICALS CORPORATION
07/29
Adamis Pharmaceuticals Corporation fait le point sur l'étude clinique évaluant Tempol p..
06/01
Adamis Pharmaceuticals reçoit la recommandation du Data Safety Monitoring Board de pour..
06/01
Adamis Pharmaceuticals Corporation fait le point sur l'étude clinique évaluant le Tempo..
05/26
Adamis Pharmaceuticals Corporation nomme Vickie Reed au conseil d'administration
05/18
Adamis Pharmaceuticals nomme David Marguglio, Chief Business Officer, au poste de PDG
05/18
Adamis Pharmaceuticals annonce une transition de direction pour soutenir une nouvelle p..
05/18
Adamis Pharmaceuticals annonce des changements dans sa direction
05/16
Adamis Pharmaceuticals réduit sa perte nette au 1er trimestre ; le revenu diminue
05/16
Adamis Pharmaceuticals Corporation annonce ses résultats pour le premier trimestre clos..
03/31
Adamis Pharmaceuticals Corporation annonce ses résultats pour l'exercice complet clos l..
More news
Press releases
07:31a
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call ..
AQ
08/01
ADAMIS PHARMACEUTICALS
: Provides Update on Clinical Study Assessing Tempol for the Treatm..
PU
08/01
ADAMIS PHARMACEUTICALS CORP
: Other Events (form 8-K)
AQ
08/01
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
08/01
Adamis Pharmaceuticals Corporation - Leading Independent Proxy Advisory Firm ISS Recomm..
AQ
More press releases
Powered by Scoopnest.com
Upcoming event on ADAMIS PHARMACEUTICALS CORPORATION
08/12/22
Annual General Meeting
Company calendar
Upcoming sector events
10/18/22
JOHNSON & JOHNSON
: Q3 2022 Earnings Release
11/01/22
PFIZER INC.
: Q3 2022 Earnings Release (Projected)
11/01/22
ELI LILLY AND COMPANY
: Q3 2022 Earnings Release
11/04/22
ABBVIE INC.
: Q3 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals
Slave